Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers

Overview of attention for article published in Frontiers in oncology, October 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,675 followers.

RT @FrontOncology: New research: Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigment…

27 Oct 2023

Reply Repost Favourite

New research: Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers: Background Xeroderma pigmentosum (XP), a rare disease with defects… https://t.co

26 Oct 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.